Franchise Network Stagnation
Franchise count remained flat at 180-190 over 3 years after a failed experiment with non-medical franchise owners. Management pivoted to hospital growth but hasn't demonstrated franchise scaling capability.
VAIDYASANEAYURVEDLABORAT / bear-case history
Track the concerns that keep returning.
Vaidyasaneayurvedlaborat · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
Care Plan Conversion Decline
Annual therapy conversions declined from 33,800 in FY25 to 28-29,000 in FY26. Analyst flagged this as concerning; management attributed to excluding smaller diet care plans but didn't provide consolidated conversion data.
H2 EBITDA Margin Compression
H2 EBITDA (excluding other income) was ₹6.80 Cr on revenue of ₹56.96 Cr (~11.9% margin), down from ₹8.56 Cr in H2 FY25. Management cited ₹50-60 lakh/month call center costs but did not quantify total H2 margin impact.
Pending Insurance Empanelment and Regulatory Approvals
Three hospitals awaiting CGHS portal activation despite NABH approval; Nagpur hospital expansion awaiting government permissions. Delays could impact FY27 bed capacity targets.